Dopamine Hydrochloride In Dextrose
NADAC/unit
N/A
Active Shortage
Active Shortages
2025-08-27 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2017-11-06 Shortage reported, Hospira, Inc., a Pfizer Company
2017-11-06 Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay, Hospira, Inc., a Pfizer Company
2017-11-06 Shortage reported, Hospira, Inc., a Pfizer Company
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.